This excerpt taken from the ELN 6-K filed Mar 31, 2006.
Investment gains amounted to $17.9 million for 2005, compared to $163.9 million for 2004. The gains on investments in 2005 primarily relate to gains on the disposal of investments in Allergy Therapeutics, plc. of $10.0 million, Iomai Corporation (Iomai) of $3.2 million, and Emisphere Technologies, Inc. (Emisphere) of $1.7 million. In 2004, the gains on investments included gains on the disposal of investments in DOV Pharmaceuticals, Inc. of $49.1 million, Warner Chilcott, plc of $43.6 million, and Atrix Laboratories of $27.7 million.